{"title":"TIM-3作为癌症患者诊断和预后生物标志物的前景","authors":"Fengling Chen, Qiaoying Chen, Liping Zhong, Yongxiang Zhao","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>T cell immunoglobulin mucin-3 (TIM-3) is expressed on the surface of most immune cells and is involved in anti-tumor immunity. In recent years, diagnoses and therapies based on the TIM-3 target have advanced substantially in clinical trials. In this review, we summarized the progress of TIM-3 as a biomarker in the field of diagnosis and prognosis of cancer. In the peripheral blood of cancer patients, the expression level of TIM-3 on T cells is significantly higher than that of control samples, which can be a physiological indicator of cancer. Moreover, in the cancer tissue of patients, the high expression level of TIM-3 on tumor-infiltrating T cells is negatively correlated with relapse-free survival time, which can act as a promising prognostic marker. In conclusion, the TIM-3 is a promising biomarker for the diagnosis and prognosis of cancer.</p>","PeriodicalId":11379,"journal":{"name":"Discovery medicine","volume":"31 162","pages":"15-20"},"PeriodicalIF":2.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prospects of TIM-3 as a Promising Diagnostic and Prognostic Biomarker for Cancer Patients.\",\"authors\":\"Fengling Chen, Qiaoying Chen, Liping Zhong, Yongxiang Zhao\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>T cell immunoglobulin mucin-3 (TIM-3) is expressed on the surface of most immune cells and is involved in anti-tumor immunity. In recent years, diagnoses and therapies based on the TIM-3 target have advanced substantially in clinical trials. In this review, we summarized the progress of TIM-3 as a biomarker in the field of diagnosis and prognosis of cancer. In the peripheral blood of cancer patients, the expression level of TIM-3 on T cells is significantly higher than that of control samples, which can be a physiological indicator of cancer. Moreover, in the cancer tissue of patients, the high expression level of TIM-3 on tumor-infiltrating T cells is negatively correlated with relapse-free survival time, which can act as a promising prognostic marker. In conclusion, the TIM-3 is a promising biomarker for the diagnosis and prognosis of cancer.</p>\",\"PeriodicalId\":11379,\"journal\":{\"name\":\"Discovery medicine\",\"volume\":\"31 162\",\"pages\":\"15-20\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Discovery medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discovery medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Prospects of TIM-3 as a Promising Diagnostic and Prognostic Biomarker for Cancer Patients.
T cell immunoglobulin mucin-3 (TIM-3) is expressed on the surface of most immune cells and is involved in anti-tumor immunity. In recent years, diagnoses and therapies based on the TIM-3 target have advanced substantially in clinical trials. In this review, we summarized the progress of TIM-3 as a biomarker in the field of diagnosis and prognosis of cancer. In the peripheral blood of cancer patients, the expression level of TIM-3 on T cells is significantly higher than that of control samples, which can be a physiological indicator of cancer. Moreover, in the cancer tissue of patients, the high expression level of TIM-3 on tumor-infiltrating T cells is negatively correlated with relapse-free survival time, which can act as a promising prognostic marker. In conclusion, the TIM-3 is a promising biomarker for the diagnosis and prognosis of cancer.
期刊介绍：
Discovery Medicine publishes novel, provocative ideas and research findings that challenge conventional notions about disease mechanisms, diagnosis, treatment, or any of the life sciences subjects. It publishes cutting-edge, reliable, and authoritative information in all branches of life sciences but primarily in the following areas: Novel therapies and diagnostics (approved or experimental); innovative ideas, research technologies, and translational research that will give rise to the next generation of new drugs and therapies; breakthrough understanding of mechanism of disease, biology, and physiology; and commercialization of biomedical discoveries pertaining to the development of new drugs, therapies, medical devices, and research technology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
